When It Happens Panel Get involved: send your photos, videos, news & views by texting 'OXFORD NEWS' to 80360 or email
10:10am Saturday 28th September 2013 in News
The behaviour of a protein in the body that sometimes boosts tumour cell growth and at other times restricts it has been explained by Oxford scientists.
Their groundbreaking research could lead to the creation of new cancer drugs.
It concerns the protein E2F, nicknamed ‘Jekyll-and-Hyde’, which is inextricably linked to cancer.
In many cancer cases, E2F oversees processes which keep deadly cells growing.
However, on other occasions it helps to kill off cells which could become cancerous.
Oxford University scientists have identified compounds, which are active chemicals in the body, that can block the protein’s change “from Dr Jeckyll to Mr Hyde” and result in the death of cancer cells.
Comments are closed on this article.